More articles from Myelodysplastic Syndromes

Effects of erythropoiesis-stimulating agents on overall survival of IPSS low/INT-1 risk, transfusion independent myelodysplastic syndrome patients: a cohort study
Emanuela Messa, Daniela Gioia, Elisa Masiera, Anna Castiglione, Manuela Ceccarelli, Flavia Salvi, Paolo Danise, Alessandro Sanna, Bernardino Allione, Enrico Balleari, Antonella Poloni, Giovanni Cametti, Dario Ferrero, Rodolfo Tassara, Carlo Finelli, Margherita Bonferroni, Pellegrino Musto, Giuseppe Saglio, Alessandro Levis, Valeria Santini

Haematologica Aug 2018, haematol.2017.183590; DOI: 10.3324/haematol.2017.183590
Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice
Xin Jin, Xiaoyuan He, Xiaoli Cao, Ping Xu, Yi Xing, Songnan Sui, Luqiao Wang, Juanxia Meng, Wenyi Lu, Rui Cui, Hongyan Ni, Mingfeng Zhao

Haematologica Jun 2018, haematol.2018.193128; DOI: 10.3324/haematol.2018.193128
L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
Erica Bello, Jonathan Kerry, Shalini Singh, Bon Ham Yip, Rajko Kušec, Sally Killick, Sophie Raynaud, Jacqueline Boultwood, Andrea Pellagatti

Haematologica Jun 2018, haematol.2018.190447; DOI: 10.3324/haematol.2018.190447
Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells
Maria Krevvata, Xiaochuan Shan, Chenghui Zhou, Cedric Dos Santos, Georges Habineza Ndikuyeze, Anthony Secreto, Joshua Glover, Winifred Trotman, Gisela Brake-Silla, Selene Nunez-Cruz, Gerald Wertheim, Hyun-Jeong Ra, Elizabeth Griffiths, Charalampos Papachristou, Gwenn Danet-Desnoyers, Martin Carroll

Haematologica Jun 2018, 103 (6) 959-971; DOI: 10.3324/haematol.2017.183202
The long non-coding RNA landscape in juvenile myelomonocytic leukemia
Mattias Hofmans, Tim Lammens, Hetty H Helsmoortel, Silvia Bresolin, Hélène Cavé, Christian Flotho, Henrik Hasle, Marry M. van den Heuvel-Eibrink, Charlotte Niemeyer, Jan Stary, Nadine Van Roy, Pieter Van Vlierberghe, Jan Philippé, Barbara De Moerloose

Haematologica Jun 2018, haematol.2018.189977; DOI: 10.3324/haematol.2018.189977
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia
Stefanie Geyh, Manuel Rodríguez-Paredes, Paul Jäger, Annemarie Koch, Felix Bormann, Julian Gutekunst, Christoph Zilkens, Ulrich Germing, Guido Kobbe, Frank Lyko, Rainer Haas, Thomas Schroeder

Haematologica May 2018, haematol.2017.186734; DOI: 10.3324/haematol.2017.186734
Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7
Victor B. Pastor, Sushree S. Sahoo, Jessica Boklan, Georg C. Schwabe, Ebru Saribeyoglu, Brigitte Strahm, Dirk Lebrecht, Matthias Voss, Yenan T. Bryceson, Miriam Erlacher, Gerhard Ehninger, Marena Niewisch, Brigitte Schlegelberger, Irith Baumann, John C. Achermann, Akiko Shimamura, Jochen Hochrein, Ulf Tedgård, Lars Nilsson, Henrik Hasle, Melanie Boerries, Hauke Busch, Charlotte M. Niemeyer, Marcin W. Wlodarski

Haematologica Mar 2018, 103 (3) 427-437; DOI: 10.3324/haematol.2017.180778
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes
Louise de Swart, Chloé Reiniers, Timothy Bagguley, Corine van Marrewijk, David Bowen, Eva Hellström-Lindberg, Aurelia Tatic, Argiris Symeonidis, Gerwin Huls, Jaroslav Cermak, Arjan A. van de Loosdrecht, Hege Garelius, Dominic Culligan, Mac Macheta, Michail Spanoudakis, Panagiotis Panagiotidis, Marta Krejci, Nicole Blijlevens, Saskia Langemeijer, Jackie Droste, Dorine W. Swinkels, Alex Smith, Theo de Witte

Haematologica Jan 2018, 103 (1) 69-79; DOI: 10.3324/haematol.2017.171884
Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway
Ekaterina Balaian, Manja Wobus, Heike Weidner, Ulrike Baschant, Maik Stiehler, Gerhard Ehninger, Martin Bornhäuser, Lorenz C Hofbauer, Martina Rauner, Uwe Platzbecker

Haematologica Jan 2018, 103 (1) 61-68; DOI: 10.3324/haematol.2017.172726
Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes
Thomas Cluzeau, Kathy L. McGraw, Brittany Irvine, Erico Masala, Lionel Ades, Ashley A. Basiorka, Jaroslaw Maciejewski, Patrick Auberger, Sheng Wei, Pierre Fenaux, Valeria Santini, Alan List

Haematologica Dec 2017, 102 (12) 2015-2020; DOI: 10.3324/haematol.2016.158857

More articles from Myelodysplastic Syndromes

Pages